Article info
PDFCorrespondence
Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors
- Correspondence to Dr David M Kofler, Department I of Internal Medicine, University of Cologne, Cologne 50937, Germany; david.kofler{at}uk-koeln.de
Citation
Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors
Publication history
- Received November 1, 2019
- Accepted November 5, 2019
- First published November 19, 2019.
Online issue publication
November 12, 2021
Article Versions
- Previous version (19 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.